Condition
Treatment Compliance
ClinicalTrials.gov condition label
Clinical trials
10 shownEfficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid ArthritisNCT07491016 · 2026-03-01
RECRUITINGEfficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid ArthritisNCT06979271 · 2025-06-01
RECRUITINGALHIV Smartphone Game StudyNCT06913660 · 2025-04-07
COMPLETEDTTM-Based Social Media Psychoeducation for PsychosisNCT07080827 · 2025-03-01
ACTIVE_NOT_RECRUITINGData Science and Qualitative Research for Decision Support in the HIV Care CascadeNCT06604663 · 2024-05-20
ENROLLING_BY_INVITATIONEfficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid ArthritisNCT05451615 · 2022-09-30
UNKNOWNCulturally Aware AET Non-Initiation InterventionNCT05465408 · 2022-07-21
COMPLETEDIntegrative Nursing Based Multimodal Interventions for Uncontrolled HypertensivesNCT04809519 · 2021-10-06
COMPLETEDTelehealth Follow-up in Patients With Rheumatoid ArthritisNCT04536844 · 2020-06-15
UNKNOWNAntihypertensive and PAP Treatment in Obstructive Sleep Apnea Patients With Hypertension (AHPAP)NCT05115994 · 2008-01-01
ACTIVE_NOT_RECRUITINGCommon interventions
AbataceptDRUG1Activation of the CDSS systemBEHAVIORAL1Continous positive airway pressureDEVICE1Conventional prescheduled follow-upOTHER1Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation InterventionBEHAVIORAL1Integrative Nursing based Multimodal Interventions for Uncontrolled HypertensivesOTHER1Janus Kinase InhibitorDRUG1Mobile application MyDignio (follow disease activity by assigning questionnaires to participants)DEVICE1MyGoalsBEHAVIORAL1Ongoing treatmentOTHER1Standard Face-to-Face Psychoeducation ProgramBEHAVIORAL1Standard of careBEHAVIORAL1Telitacicept TofacitinibDRUG1TTM-Based Online Psychoeducation ProgramBEHAVIORAL1TTM-Based Online Psychoeducation ProgramOTHER1
Leading sponsors
Trial status mix
COMPLETED3
ACTIVE_NOT_RECRUITING2
RECRUITING2
UNKNOWN2
ENROLLING_BY_INVITATION1
Phase mix
NA6
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.